Verition Fund Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-7,814
| Closed | -$769K | – | 3735 |
|
|
2025
Q2 | $769K | Sell |
7,814
-117,310
| -94% | -$11.1M | ﹤0.01% | 2658 |
|
|
2025
Q1 | $11.6M | Buy |
125,124
+108,607
| +658% | +$10M | 0.05% | 402 |
|
|
2024
Q4 | $1.5M | Sell |
16,517
-98,257
| -86% | -$9.02M | 0.01% | 1756 |
|
|
2024
Q3 | $11.1M | Buy |
114,774
+98,565
| +608% | +$9.62M | 0.06% | 356 |
|
|
2024
Q2 | $1.49M | Sell |
16,209
-60,793
| -79% | -$5.64M | 0.01% | 1442 |
|
|
2024
Q1 | $7.1M | Sell |
77,002
-32,911
| -30% | -$3.08M | 0.05% | 477 |
|
|
2023
Q4 | $10.4M | Buy |
109,913
+3,134
| +3% | +$293K | 0.08% | 224 |
|
|
2023
Q3 | $9.97M | Buy |
106,779
+94,734
| +787% | +$8.75M | 0.12% | 212 |
|
|
2023
Q2 | $1.1M | Buy |
+12,045
| New | +$988K | 0.01% | 892 |
|
|
2022
Q4 | – | Sell |
-8,900
| Closed | -$861K | – | 2107 |
|
|
2022
Q3 | $861K | Buy |
+8,900
| New | +$1.06M | 0.01% | 1516 |
|
|
2022
Q1 | – | Sell |
-2,117
| Closed | -$343K | – | 2694 |
|
|
2021
Q4 | $343K | Sell |
2,117
-1,380
| -39% | -$222K | ﹤0.01% | 1917 |
|
|
2021
Q3 | $521K | Buy |
+3,497
| New | +$727K | ﹤0.01% | 1202 |
|
|
2020
Q4 | – | Sell |
-1,032
| Closed | -$244K | – | 1081 |
|
|
2020
Q3 | $244K | Buy |
+1,032
| New | +$235K | ﹤0.01% | 864 |
|
|
2019
Q2 | – | Sell |
-6,303
| Closed | -$777K | – | 1048 |
|
|
2019
Q1 | $777K | Buy |
+6,303
| New | +$791K | 0.03% | 491 |
|
|
2018
Q2 | – | Sell |
-7,169
| Closed | -$433K | – | 1059 |
|
|
2018
Q1 | $433K | Sell |
7,169
-374
| -5% | -$21.3K | 0.03% | 686 |
|
|
2017
Q4 | $398K | Buy |
+7,543
| New | +$398K | 0.04% | 560 |
|
|
2017
Q1 | – | Sell |
-7,294
| Closed | -$311K | – | 1149 |
|
|
2016
Q4 | $311K | Buy |
7,294
+2,622
| +56% | +$111K | 0.03% | 804 |
|
|
2016
Q3 | $222K | Buy |
+4,672
| New | +$233K | 0.02% | 945 |
|
Other funds holding AMED
IA
MCI
HNB
Verition Fund Management's AMED Position: Q3 2025 in Review
Verition Fund Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 7,814 shares — an estimated $769K sold.
Verition Fund Management first reported a position in AMED in Q3 2016 and held it in 18 quarters. The position peaked at $11.6M in Q1 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Verition Fund Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Verition Fund Management sold 7,814 Amedisys shares in Q3 2025, an estimated $769K.
- Verition Fund Management first reported a position in Amedisys in Q3 2016 and held it in 18 quarters.
- Verition Fund Management's Amedisys position peaked at $11.6M in Q1 2025.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Verition Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.